2010/11至2013/14流感季医疗保险人群流感疫苗接种后吉兰-巴雷综合征的近实时监测
2010/11季观察到GBS风险信号,季末SCRI分析RR=1.25(95%CI 0.96-1.63),敏感性分析RR=1.98(95%CI 1.42-2.76);后续三季未再观察到信号。
要点
- 2010/11季观察到GBS风险信号,季末SCRI分析RR=1.25(95%CI 0.96-1.63),未达统计学显著。
- 应用2009/10季ICD-9编码阳性预测值的敏感性分析估计RR=1.98(95%CI 1.42-2.76)。
- 2011/12季监测相同疫苗未发现接种后GBS风险升高,后续三季均未观察到信号。
核心结论
- 使用USPRT进行近实时监测是流感疫苗接种后GBS监测的优秀方法,2010/11季能早期观察到信号,该方法已成为常规。
研究设计与样本
- 采用更新序贯概率比检验(USPRT),总体单侧α=0.05,通过恒定α消耗计划在20次连续周检、5次临时检验和第26次季末最终检验间等分。
- 观察到的信号采用自控风险区间(SCRI)设计进行调查。
主要发现
- 2010/11流感季观察到GBS风险升高,季末SCRI分析发现非显著的风险增加(RR=1.25,95%CI 0.96-1.63)。
- 应用2009/10季GBS的ICD-9编码阳性预测值的敏感性分析估计RR=1.98(95%CI 1.42-2.76)。
- 2010/11流感疫苗提示GBS风险增加,但2011/12流感季监测相同疫苗未发现接种后GBS风险增加。
- 后续三个流感季未观察到信号。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guillain-Barré syndrome (GBS) is a serious acute demyelinating disease that causes weakness and paralysis. The Food and Drug Administration (FDA) began collaborating with the Centers for Medicare and Medicaid Services (CMS) to develop near real-time vaccine safety surveillance capabilities in 2006 and has been monitoring for the risk of GBS after influenza vaccination for every influenza season since 2008. METHODS: We present results from the 2010/11 to 2013/14 influenza seasons using the Updating Sequential Probability Ratio Test (USPRT), with an overall 1-sided α of 0.05 apportioned equally using a constant alpha-spending plan among 20 consecutive weekly tests, 5 ad hoc tests, and a 26th final end of season test. Observed signals were investigated using the self-controlled risk interval (SCRI) design. RESULTS: Over 15 million people were vaccinated in each influenza season. In the 2010/11 influenza season, we observed an elevated GBS risk during the season, with an end of season SCRI analysis finding a nonsignificant increased risk (RR=1.25, 95% CI: 0.96-1.63). A sensitivity analysis applying the positive predictive value of the ICD-9 code for GBS from the 2009/10 season estimated a RR=1.98 (95% CI: 1.42-2.76). Although the 2010/11 influenza vaccine suggested an increased GBS risk, surveillance of the identical vaccine in the 2011/12 influenza season did not find an increased GBS risk after vaccination. No signal was observed in the subsequent three influenza seasons. CONCLUSIONS: Conducting near real-time surveillance using USPRT has proven to be an excellent method for near real-time GBS surveillance after influenza vaccination, as demonstrated by our surveillance efforts during the 2010/11-2013/14 influenza seasons. In the 2010/2011 influenza season, in addition to the 2009 H1N1 influenza pandemic, using near real-time surveillance we were able to observe a signal early in the influenza season and the method has now become routine.
引用
- Sandhu SK, Hua W, MaCurdy TE, et al. Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14. Vaccine. 2017. PMID: 28449973. doi:10.1016/j.vaccine.2017.03.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。